Septerna, Inc.
corporate_fare Company Profile
Septerna, Inc. (NASDAQ:SEPN) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 16 items for SEPN at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-09, rated 7/10. Across its 16 most recent items scored 7 or higher, the top rating is 9/10, with 5 rated 8 or above. Recent SEC coverage for SEPN spans 10-Q, 8-K, SCHEDULE 13D/A, 144.
Recent high-impact activity:
- Septerna 10-Q: Q3 Revenue $18.9M, Net Loss $26.6M, $565.2M Cash Into Mid-2029
- Septerna Posts $18.9M in Third-Quarter Revenue
- Septerna Names SEP-204 Development Candidate for Graves' Disease and TED; Phase 1 Set for Q1 2027
- RA Capital Sells 1.49M Septerna Shares at $42.50 in Block Trades
- RA Capital Files to Sell $36M of Septerna Shares
Financial Snapshot
Short Interest & Short Volume
11.95 days to coverFINRA reported short interest of 3,352,395 shares in SEPN as of the October 30, 2026 settlement, a 4.8% decrease from the prior period — about 11.9 days to cover at its recent average daily volume. On November 19, 2026, 72.6% of SEPN volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.